The relationship between oligoclonal band status and serum viral antibodies with cerebrospinal fluid viral load in newly diagnosed multiple sclerosis
ECTRIMS 2025, Barcelona, İspanya, 24 - 26 Eylül 2025, ss.982-983, (Tam Metin Bildiri)
- Yayın Türü: Bildiri / Tam Metin Bildiri
- Basıldığı Şehir: Barcelona
- Basıldığı Ülke: İspanya
- Sayfa Sayıları: ss.982-983
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Gazi Üniversitesi Adresli: Evet
Özet
Objectives/Aims: This study aimed to investigate the relation-
ship between oligoclonal band (OCB) status and IgG index
value in cerebrospinal fluid (CSF) and serum viral antibodies
with CSF viral load in newly diagnosed MS.
Methods: Two hundred-sixty one newly diagnosed MS patients
were included in the study and evaluated retrospectively in
between December 2022 and March 2024. Serum IgM-IgG anti-
bodies for Epstein-Barr virus (EBV), herpes simplex virus (HSV)
1-2, cytomegalovirus (CMV), and varicella-zoster virus (VZV)
were assessed at the time of diagnosis, additionally, PCR analysis
was performed in CSF to detect these viruses. Serum antinuclear
antibody (ANA) levels were also recorded. The relationship
between the CSF OCB status and IgG index value and serum viral
antibodies and presence of CSF viral PCR, as well as the correla-
tion of these parameters with age, gender, first attack clinic, lesion
location and number on MRI were examined.
Results: 86.2% of the patients were OCB positive, with 87.1%
classified as Type 2 and 12.9% as Type 3. Serum EBV VCA and
EBNA IgG, HSV1, HSV2, CMV, VZV IgG antibodies were
positive at a frequency of 80/82 (%97.6), 59/76 (%77.6), 6/76
(%7.9), 46/47 (%97.9) and 91/93 (%97.8), while serum IgM
antibodies were negative in all cases. All CSF PCR results were
negative. There was no significant relationship between CSF
OCB positivity and type, increased IgG index, and all serum
viral IgG positivity (p>0.05). However, serum ANA positivity
was significantly higher in OCB-positive patients (32.6%) com-
pared to OCB-negative patients (11.1%) (p=0.035), suggesting a
potential involvement of both central and peripheral immune
activation in MS pathogenesis.